OMFRELA (registration number 6770261) is a United States trademark of DAIICHI SANKYO COMPANY, LIMITED. The goods and services are: Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, metastasis, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases; vaccines . The correspondent is TANIYAMA Takashi.
This trademark was filed on October 19, 2021 as United States Trademark Application Serial Number 79326278.
Trademark PTO Status
20220703 – NEW REPRESENTATIVE AT IB RECEIVED
20220628 – REGISTERED-PRINCIPAL REGISTER
20220412 – PUBLISHED FOR OPPOSITION
20220323 – NOTICE OF PUBLICATION
20220308 – APPROVED FOR PUB – PRINCIPAL REGISTER
20220307 – ASSIGNED TO EXAMINER
20211208 – APPLICATION FILING RECEIPT MAILED
20211204 – NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Ownership History
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO COMPANY, LIMITED
File a Trademark
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.